Skip to content

ESWT VS Local corticosteroid injection for the treatment of CTS; Functional, electrodiagnosis and neuromuscular ultrasound assessment: A Randomized Controlled

ESWT VS Local corticosteroid injection for the treatment of CTS; Functional, electrodiagnosis and neuromuscular ultrasound assessment: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20150709001
Enrollment
178
Registered
2015-07-09
Start date
2015-07-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carpal tunnel syndrome Dull&#44

Interventions

A sequence of single sonic pulses characterized by a high peak pressure (100 MPa)&#44
fast pressure rise (<10 nsecs)&#44
and short duration (10 microsecs),The 1 ml of Triamcinolone (acetonide) 10 mg mixed with 1% lidocaine 1 ml in a 3 ml disposable syringe. The injection into the carpal tunnel was done with a 25 gauge&#
needle one centimeter proximal to the wrist&#45
flexion crease
Experimental Device,Experimental Device
extracorporeal shockwave,Local corticosteroid injection

Sponsors

Faculty of Medicine
Lead Sponsor
Faculty of Medicine
Collaborator

Eligibility

Sex/Gender
All
Age
19 Years to 80 Years

Inclusion criteria

Inclusion criteria: CTS patients who are at least 19 years of age are enrolled based on their history and physical examination follow the American Academy of Neurology (AAN) for CTS with diagnostic criteria and EDX criteria from AAEM in mild and moderate degrees.

Exclusion criteria

Exclusion criteria: Patients with underlying metabolic disorders such as diabetes mellitus&#44; genetic disorders&#44; upper limb surgery&#44; peripheral polyneuropathy&#44; traumatic nerve injury&#44; blood coagulation disorder or during the use of anticoagulants&#44; pregnancy&#44; thrombosis&#44; cancer and previous surgical&#44; wrist splint or injection CTS treatment. Excluded severe CTS patients according to electrodiagnosis criteria.

Design outcomes

Primary

MeasureTime frame
Mean symptom score and function score baseline (prior to performing the intervention) and at 1 week&#44; 1 month&#44; 3 month&#44; and 6 months Thai version Boston self&#45;assessment questionnaire

Secondary

MeasureTime frame
Mean visual analog scale&#44; Mean motor latency&#44; Mean motor amplitude&#44; Mean sensory latency&#44; baseline (prior to performing the intervention) and at 1 week&#44; 1 month&#44; 3 month&#44; and 6 months Visual analog scale (VAS) and electrodiagnosis ,Mean nerve crossectional area baseline (prior to performing the intervention) and at 1 month&#44; 3 month&#44; and 6 months after ultrasound

Contacts

Public ContactPichitchai Atthakomol

Faculty of Medicine&#44; Chiang Mai University

notty_08@hotmail.cpm+66840410786

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026